Product logins

Find logins to all Clarivate products below.


Neurostimulation Devices | Market Insights | Europe (Supplemental) | 2021

Although it will be negatively impacted in the short term by the COVID-19 pandemic, the European neurostimulation device market is growing modestly, and will be buoyed over the forecast period by the ongoing launch of premium-priced products. 

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the neurostimulation device market in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Neurostimulation Devices – Market Insights – United States
The US neurostimulation device market will be driven by strategic acquisitions, rapid adoption of novel technologies and increasing availability of advanced products, and new approvals and device…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…